144 related articles for article (PubMed ID: 7600636)
1. Recombinant E. coli-derived tissue factor pathway inhibitor reduces coagulopathic and lethal effects in the baboon gram-negative model of septic shock.
Carr C; Bild GS; Chang AC; Peer GT; Palmier MO; Frazier RB; Gustafson ME; Wun TC; Creasey AA; Hinshaw LB
Circ Shock; 1994 Nov; 44(3):126-37. PubMed ID: 7600636
[TBL] [Abstract][Full Text] [Related]
2. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock.
Creasey AA; Chang AC; Feigen L; Wün TC; Taylor FB; Hinshaw LB
J Clin Invest; 1993 Jun; 91(6):2850-60. PubMed ID: 8514893
[TBL] [Abstract][Full Text] [Related]
3. Antithrombin-III prevents the lethal effects of Escherichia coli infusion in baboons.
Taylor FB; Emerson TE; Jordan R; Chang AK; Blick KE
Circ Shock; 1988 Nov; 26(3):227-35. PubMed ID: 3061681
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of tissue thrombosis and hemorrhage by ala-TFPI does not account for its protection against E. coli--a comparative study of treated and untreated non-surviving baboons challenged with LD100 E. coli.
Randolph MM; White GL; Kosanke SD; Bild G; Carr C; Galluppi G; Hinshaw LB; Taylor FB
Thromb Haemost; 1998 May; 79(5):1048-53. PubMed ID: 9609245
[TBL] [Abstract][Full Text] [Related]
5. Studies on the inflammatory-coagulant axis in the baboon response to E. coli: regulatory roles of proteins C, S, C4bBP and of inhibitors of tissue factor.
Taylor FB
Prog Clin Biol Res; 1994; 388():175-94. PubMed ID: 7831358
[TBL] [Abstract][Full Text] [Related]
6. Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia.
de Jonge E; Dekkers PE; Creasey AA; Hack CE; Paulson SK; Karim A; Kesecioglu J; Levi M; van Deventer SJ; van Der Poll T
Blood; 2000 Feb; 95(4):1124-9. PubMed ID: 10666180
[TBL] [Abstract][Full Text] [Related]
7. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.
Taylor FB; Chang A; Esmon CT; D'Angelo A; Vigano-D'Angelo S; Blick KE
J Clin Invest; 1987 Mar; 79(3):918-25. PubMed ID: 3102560
[TBL] [Abstract][Full Text] [Related]
8. Endotoxin and cytokine profile in plasma of baboons challenged with lethal and sublethal Escherichia coli.
Creasey AA; Stevens P; Kenney J; Allison AC; Warren K; Catlett R; Hinshaw L; Taylor FB
Circ Shock; 1991 Feb; 33(2):84-91. PubMed ID: 2049816
[TBL] [Abstract][Full Text] [Related]
9. The impact of tissue factor pathway inhibitor on coagulation kinetics determined by thrombelastography.
Audu P; Nielsen VG; Armstead V; Powell G; Kim J; Kim L; Mehta M
Anesth Analg; 2006 Oct; 103(4):841-5. PubMed ID: 17000790
[TBL] [Abstract][Full Text] [Related]
10. Effect of C1 inhibitor on inflammatory and physiologic response patterns in primates suffering from lethal septic shock.
Jansen PM; Eisele B; de Jong IW; Chang A; Delvos U; Taylor FB; Hack CE
J Immunol; 1998 Jan; 160(1):475-84. PubMed ID: 9552006
[TBL] [Abstract][Full Text] [Related]
11. Recombinant activated protein C attenuates endothelial injury and inhibits procoagulant microparticles release in baboon heatstroke.
Bouchama A; Kunzelmann C; Dehbi M; Kwaasi A; Eldali A; Zobairi F; Freyssinet JM; de Prost D
Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1318-25. PubMed ID: 18451327
[TBL] [Abstract][Full Text] [Related]
12. The effect of two-domain tissue factor pathway inhibitor on endotoxin-induced disseminated intravascular coagulation in rabbits.
Bregengård C; Nordfang O; Wildgoose P; Svendsen O; Hedner U; Diness V
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):699-706. PubMed ID: 8292719
[TBL] [Abstract][Full Text] [Related]
13. Tissue factor pathway inhibitor: structure, biology and involvement in disease.
Lwaleed BA; Bass PS
J Pathol; 2006 Feb; 208(3):327-39. PubMed ID: 16261634
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human antithrombin III improves survival and attenuates inflammatory responses in baboons lethally challenged with Escherichia coli.
Minnema MC; Chang AC; Jansen PM; Lubbers YT; Pratt BM; Whittaker BG; Taylor FB; Hack CE; Friedman B
Blood; 2000 Feb; 95(4):1117-23. PubMed ID: 10666179
[TBL] [Abstract][Full Text] [Related]
15. The coagulation and fibrinolytic responses of baboons after in vivo thrombin generation--effect of interleukin 6.
Kruithof EK; Mestries JC; Gascon MP; Ythier A
Thromb Haemost; 1997 May; 77(5):905-10. PubMed ID: 9184401
[TBL] [Abstract][Full Text] [Related]
16. Fragmented tissue factor pathway inhibitor (TFPI) and TFPI C-terminal peptides eliminate serum-resistant Escherichia coli from blood cultures.
Schirm S; Liu X; Jennings LL; Jedrzejewski P; Dai Y; Hardy S
J Infect Dis; 2009 Jun; 199(12):1807-15. PubMed ID: 19456231
[TBL] [Abstract][Full Text] [Related]
17. The effect of adrenocorticosteroid pretreatment on kinin system and coagulation response to septic shock in the baboon.
Herman CM; Oshima G; Erdös EG
J Lab Clin Med; 1974 Nov; 84(5):731-9. PubMed ID: 4283795
[No Abstract] [Full Text] [Related]
18. Microthrombosis in sepsis.
Vallet B
Minerva Anestesiol; 2001 Apr; 67(4):298-301. PubMed ID: 11376528
[TBL] [Abstract][Full Text] [Related]
19. Extremely low doses of tissue factor pathway inhibitor decrease mortality in a rabbit model of septic shock.
Matyal R; Vin Y; Delude RL; Lee C; Creasey AA; Fink MP
Intensive Care Med; 2001 Aug; 27(8):1274-80. PubMed ID: 11511939
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of treatment with the iron (III) complex of diethylenetriamine pentaacetic acid in mice and primates inoculated with live lethal dose 100 Escherichia coli.
Molina L; Studenberg S; Wolberg G; Kazmierski W; Wilson J; Tadepalli A; Chang AC; Kosanke S; Hinshaw L
J Clin Invest; 1996 Jul; 98(1):192-8. PubMed ID: 8690793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
